Harrison Street Acquisition of Life Science Lab at Kendall Square

Deal value: $158,000,000

Acquisition of a 110,000 sq. ft. life science and laboratory building in Cambridge, Massachusetts.

The core investment motivation is to gain exposure to a premier life science and laboratory asset in Kendall Square, Cambridge, a globally recognized hub for biotech and innovation. The acquisition targets a fully leased, state-of-the-art complex with blue-chip tenants like Pfizer, Novartis, and LabCentral, capitalizing on extremely low vacancy rates and high barriers to entry. The timing is driven by surging demand for life science space, limited supply, and the strategic adjacency to MIT and leading research institutions.